To evaluate safety and benefit of Ahaglow (GlycOlic acid, Aloe veRa and Vitamin-E) based face wash for daily use in Acne Prone Ski
Not Applicable
- Conditions
- Health Condition 1: L709- Acne, unspecified
- Registration Number
- CTRI/2023/06/053763
- Lead Sponsor
- Torrent Pharmaceuticals Ltd,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients suffering from acne skin conditions currently receiving medical management as tretinoin or adapalene with or without BPO.
2) Clinical cases requiring complementary add on or maintenance therapy.
Exclusion Criteria
1) Allergic skin diseases other than cases of Acne.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety Assessment - Incidence of treatment emergent adverse events (TEAEs) [i.e.Safety and Tolerability] occurring during the course of treatment will be recorded for safety parameter. <br/ ><br>Timepoint: At 4 weeks
- Secondary Outcome Measures
Name Time Method Patient assessed outcomes for Quality of lifeTimepoint: 4 weeks